Filter Results :

Your search for antibod returned 127 reports

Sort by


Competitor Analysis: Specific and Bispecific Her3 Antibodies

16 Feb 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about Specific and Bispecific Her3 Antibodies provides a competitor evaluation in the field of recombinant specific antibodies targeting Her3 or bispecific antibodies targeting Her3 and Her2 or EGF-R or other targets for treatment of cancer as of February 2...

$ 223.71

Read More

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin

15 Feb 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin provides a competitor evaluation in the field of recombinant antibodies targeting Her2 for treatment of Her2 positive breast and gastric cancer as of February 2015. Purchase of the downl...

$ 335.56

Read More

Competitor Analysis: VEGF & VEGF-R Antibodies 2015 - Biosimilars and Biosuperiors of Avastin and Lucentis

08 Feb 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about VEGF and VEGF-R Antibodies 2015 - Biosimilars and Biosuperiors of Avastin and Lucentis provides a competitor evaluation in the field of recombinant antibodies targeting vascular endothelial growth factor (VEGF) or its receptors (VEGF-R) used to treat ...

$ 391.49

Read More

Antibody Partnering Terms and Agreements

01 Jan 2015  |  Published by:  CurrentPartnering
The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why ...

$ 2,995.00

Read More

Antibody Drugs: Technologies and Global Markets

01 Jan 2015  |  Published by:  BCC Research
The global market for antibody drugs was worth nearly $63.4 billion in 2013. This market is expected to grow at a compound annual growth rate (CAGR) of 12.2% between 2014 and 2019 resulting in totals nearly $68.9 billion in 2014 and $122.6 billion globally in 2019. This report provides:-An ov...

$ 6,650.00

Read More

Global Markets for Research Antibodies

01 Jan 2015  |  Published by:  BCC Research
The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014. This market is expected to reach nearly $3 billion in 2019, registering a compound annual growth rate (CAGR) of 6.2% for the period 2014-2019. This report provides:-An overview of the globa...

$ 6,650.00

Read More

Monoclonal Antibody Markets in China

01 Dec 2014  |  Published by:  Asia Market Info and Dev Co.
China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & ...

$ 4,000.00

Read More

Scantibodies Laboratory, Inc. - Strategic SWOT Analysis Review

21 Nov 2014  |  Published by:  GlobalData
SummaryScantibodies Laboratory, Inc. (Scantibodies) is a biotechnology company. The company develops and manufactures medical tests and their critical components. Its products include polyclonal antibodies, monoclonal antibodies additives, heterophilic blocking reagent, redicon liquid controls, sysc...

$ 300.00

Read More

Fusion Antibodies Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

18 Nov 2014  |  Published by:  GlobalData
SummaryFusion Antibodies Ltd (Fusion Antibodies) is a contract research organization (CRO). It holds expertise and offers contract services in the production of monoclonal antibodies, antibody sequencing, antibody engineering and humanization, and antibody expression. The organization offers a wide ...

$ 250.00

Read More

4-Antibody AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

12 Nov 2014  |  Published by:  GlobalData
Summary4-Antibody AG (4-Antibody) is a biopharmaceutical company. The company develops fully-human antibody drug-discovery and optimization technology platform for discovery and development of therapeutic antibodies for the treatment of serious medical conditions such as infectious diseases, oncolog...

$ 250.00

Read More

Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019

03 Nov 2014  |  Published by:  MarketsandMarkets
Report Description Developing markets such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations. The report segments the global SUB market by molecule type, type of cell, technology, end user, and region. The mono...

$ 4,650.00

Read More

Global and China Monoclonal Antibody Industry Report, 2014-2019

21 Oct 2014  |  Published by:  ResearchInChina
Despite world-wide economic downturn and great changes in exchange rate, benefiting from robust market demand, global monoclonal antibody market size exceeded USD 80 billion in 2013, still one of biotech drugs with the fastest CAGR in recent years. Global blockbuster monoclonal antibody agents a...

$ 2,600.00

Read More

Global Cancer Monoclonal Antibodies Market & Pipeline Insight

03 Oct 2014  |  Published by:  KuicK Research
Recent years have witnessed the emergence of monoclonal antibodies, which has the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past decades, the researchers have increased their learning about the human body’s immune system, which has led to ...

$ 2,400.00

Read More

Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins

21 Sep 2014  |  Published by:  La Merie Business Intelligence
The present Competitive Intelligence Report about prophylaxis and therapy of Rabies virus infections provides a competitor evaluation in the field of marketed and new molecules for prevention or treatment of Rabies virus infections as of September 2014. Purchase of the downloadable pdf report ...

$ 223.71

Read More

Monoclonal Antibodies Partnering Terms and Agreements

01 Aug 2014  |  Published by:  CurrentPartnering
The report provides a detailed understanding and analysis of how and why companies enter monoclonal antibody partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors monoclonal antibody technology. These deal...

$ 2,995.00

Read More
Total 127 records.